In vitro assessment of clevidipine using the profilin1 hypertensive mouse model.

Pharmaceuticals (Basel) · 2013 · PMC3817727 · PMID 24276170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Additionally, clevidipine exhibited higher efficacy compared to labetolol in our model as indicated by the highly significant maximal response obtained by clevidipine at the highest dose.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.